According to a market report by Lucintel, the future of the global minimally invasive fascial closure device market looks promising with opportunities in the general hospital, specialized hospital, and clinic markets. The global minimally invasive fascial closure device market is expected to grow with a CAGR of 6.7% from 2025 to 2031. The major drivers for this market are the rising demand for minimally invasive surgical procedures, the growing awareness about reduced complications with advanced closure devices, and the increasing investments in healthcare infrastructure.
A more
than 150-page report to understand trends, opportunity and forecast in global minimally
invasive fascial closure device market to 2031 by type (winged structure and
shield structure), application (general hospitals, specialized hospital,
clinic, and others), and region (North America, Europe, Asia Pacific, and the
Rest of the World).
Lucintel
forecasts that, within the type category, winged structure is expected to witness
higher growth over the forecast period.
Within the
application category, general hospital is expected to witness the highest
growth.
Download
sample by clicking on minimally
invasive fascial closure device market.
In terms
of region, North America is expected to witness the highest growth over the
forecast period.
Teleflex
Medical, Medtronic, CooperSurgical, B. Braun, Golden Stapler, Pride Medical
Equipment, Double Medical Technology, Jiangsu Anno, Dongfeng Yihe, Portoria
Medical are the major suppliers in the minimally invasive fascial closure device market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
New Molecular Entity Drug Market
No comments:
Post a Comment